Apolipoprotein E4 Is Deficient in Inducing Macrophage ABCA1 Expression and Stimulating the Sp1 Signaling Pathway

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Okoro, Emmanuel Ugochukwu ^a   Zhao, Yanfeng ^a   Guo, ZhongMao ^a   Zhou, Lichun ^a   Lin, Xinghua ^a   Yang, Hong ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E4; CHOLESTEROL ESTER; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ZETA; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; ATP BINDING CASSETTE A1 GENE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; FOAM CELLS; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE C; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR;

EID: 84866304112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044430     Document Type: Article

References (60)

1. Shelburne FA, Quarfordt SH, (1974) A new apoprotein of human plasma very low density lipoproteins. J. Biol. Chem. 249: 1428-1433.
2. Shore VG, Shore B, (1973) Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 12: 502-507.
3. Green PHR, Glickman RM, Saudek CD, Blum CB, Tall AR, (1979) Human intestinal lipoproteins: Studies in chyluric subjects. J. Clin. Invest. 64: 233-242.
4. Weisgraber KH, Mahley RW, Assmann G, (1977) The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rat. Atherosclerosis 28: 121-140.
5. Funke H, Boyles J, Weisgraber K, EH Ludwig ea, (1984) Uptake of apolipoprotein e-containing high density lipoproteins by hepatic parenchymal cells. Arterioscler Thromb Vasc Biol 4: 452-461.
6. Mahley RW, Innerarity TL, Stanley C. Rall J, Weisgraber KH, (1984) Plasma lipoproteins: Apolipoprotein structure and function. J. Lipid Res. 25: 1277-1294.
7. Zhang W-Y, Gaynor PM, Kruth HS, (1996) Apolipoprotein e produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J. Biol. Chem. 271: 28641-28646.
8. Utermann G, Jaeschke M, Menzel J, (1975) Familial hyperlipoproteinemia type iii: Deficiency of a specific apolipoprotein (apo e-iii) in the very-low-density lipoproteins. FEBS Lett. 56: 352-355.
9. Zannis VI, Breslow JL, al GUe, (1982) Proposed nomenclature of apoe isoproteins, apoe genotypes, and phenotypes. J. Lipid Res. 23: 911-914.
10. Weisgraber KH, S C Rall J, Innerarity TL, Mahley RW, Kuusi T, et al. (1984) A novel electrophoretic variant of human apolipoprotein e. Identification and characterization of apolipoprotein e1. J Clin. Invest. 73: 1024-1033.
11. Yamamura T, Dong L-M, Yamamoto A, (1999) Characterization of apolipoprotein e7 (glu244→lys, glu245→lys), a mutant apolipoprotein e associated with hyperlipidemia and atherosclerosis. J. Lipid Res. 40: 253-259.
12. Willis F, Graff-Radford N, Pinto M, Lawson L, (2003) Apolipoprotein e4 allele frequency in young africans of ugandan descent versus african americans. J Natl Med Assoc. 95: 71-76.
13. Davignon J, Gregg RE, Sing CF, (1988) Apolipoprotein e polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21.
14. Weisgraber KH, Stanley C. Rall J, Mahley RW, (1981) Human e apoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of the apoe isoforms J. Biol. Chem. 256: 9077-9083.
15. Stanley C. Rall J, Weisgraber KH, Mahley RW, (1981) Human apolipoprotein e-the complete aminoa acid sequence. J. Biol. Chem. 257: 4171-4178.
16. Yamamoto T, Choi HW, Ryan RO, (2008) Apolipoprotein e isoform-specific binding to the low-density lipoprotein receptor. Anal Biochem. 372: 222-226.
17. Yamamoto T, Ryan R, (2007) Anionic phospholipids inhibit apolipoprotein e-low-density lipoprotein receptor interactions. Biochem Biophys Res Commun. 354: 820-824.
18. Weisgraber KH, Innerarity TL, Mahley RW, (1982) Abnormal lipoprotein receptor-binding activity of the human e apoprotein due to cysteine-arginine interchange at a singel site. J. Biol. Chem. 257: 2518-2521.
19. Willnow TE, Sheng Z, Ishibashi S, Herz J, (1994) Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264: 1471-1474.
20. Linton MF, Hasty AH, Babaev VR, Fazio S, (1998) Hepatic apo e expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J Clin. Invest. 101: 1726-1736.
21. Takahashi S, Kawarabayasi Y, Nakalt T, Sakai J, Yamamoto T, (1992) Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci 89: 9252-9256.
22. Rubinsztein DC, Cohen JC, Berger GM, Westhuyzen DRvd, Coetzee GA, et al (1990) Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin. Invest. 86: 1306-1312.
23. Heeren J, Grewal T, Jäckle S, Beisiegel U, (2001) Recycling of apolipoprotein e and lipoprotein lipase through endosomal compartments in vivo. J. Biol. Chem. 276: 42333-42338.
24. Yancey PG, Yu H, Linton MF, Fazio S, (2007) A pathway dependent on apoe, apoai, and abca1 determines formation of buoyant high density lipoprotein by macrophage foam cell. Arterioscler Thromb Vasc Biol. 27: 1123-1131.
25. Vedhachalam C, Narayanaswami V, Neto N, (2007) The c-terminal lipid-binding domain of apolipoprotein e is a highly efficient mediator of abca1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry 46: 2583-2593.
26. Heeren J, Grewal T, Laatsch A, Rottke D, Rinninger F, et al. (2003) Recycling of apoprotein e is associated with cholesterol efflux and high density lipoprotein internalization. J. Biol. Chem. 278: 14370-14378.
27. Heeren J, Grewal T, Laatsch A, (2004) Impaired recycling of apolipoprotein e4 is associated with intracellular cholesterol accumulation. J. Biol. Chem. 279: 55483-55492.
28. Mamotte CDS, Sturm M, Foo JI, (1999) Comparison of the ldl-receptor binding of vldl and ldl from apoe4 and apoe3 homozygotes. Am J Physiol Endocrinol Metab 276: E553-E557.
29. Gregg RE, Zech LA, E J Schaefer, (1986) Abnormal in vivo metabolism of apolipoprotein e4 in humans. J Clin Invest. 78: 3.
30. Ghiselli G, Schaefer EJ, Zech LA, Gregg LE, Jr HBB, (1982) Increased prevalence of apolipoprotein e4 in type v hyperlipoproteinemia. J. Clin. Invest. 70: 474-477.
31. Wilson P, Myers R, Larson M, Ordovas J, Wolf P, et al. (1994) Apolipoprotein e alleles, dyslipidemia, and coronary heart disease. The framingham offspring study. JAMA 272: 1666-1671.
32. Song Y, Stampfer MJ, Liu S, (2004) Meta-analysis: Apolipoprotein e genotypes and risk for coronary heart disease. Ann. Intern. Med. 141: 137-147.
33. Bennet AM, Angelantonio ED, Ye Z, Wensley F, (2007) Association of apolipoprotein e genotypes with lipid levels and coronary risk. JAMA 298: 1300-1311.
34. Heeren J, Beisiegel U, Grewal T, (2006) Apolipoprotein e recycling implications for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 26: 442-448.
35. Rellin L, Heeren J, Beisiegel U, (2008) Recycling of apolipoprotein e is not associated with cholesterol efflux in neuronal cells. BBA- Mol. Cell Bio. of Lipids 1781: 232-238.
36. Minagawa H, Gong J-S, Jung C-G, Watanabe A, Lund-Katz S, et al. (2009) Mechanism underlying apolipoprotein e (apoe) isoform-dependent lipid efflux from neural cells in culture. J. Neurosci. Res. 87: 2498-2508.
37. Gong J-S, Morita S-y, Kobayashi M, Handa T, Fujita SC, et al. (2007) Novel action of apolipoprotein e (apoe): Apoe isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons. J. Mol. Neurodeg. 2: 9.
38. Blue ML, Williams DL, Zucker S, Khan SA, Blum CB, (1983) Apolipoprotein e synthesis in human kidney, adrenal gland, and liver. Proc Natl Acad Sci 80: 283-287.
39. Basu SK, Brown MS, Ho YK, Havel R, Goldstein JL, (1981) Mouse macrophages synthesize and secrete a protein resembling apolipoprotein e. Proc Natl Acad Sci 78: 7545-7549.
40. Kruth HS, Skarlatos SI, Gaynor PM, Gamble W, (1994) Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J. Biol. Chem. 269: 24511-24518.
41. Mazzone T, Gump H, Diller P, Getz GS, (1987) Macrophage free cholesterol content regulates apolipoprotein e synthesis. J. Biol. Chem. 262: 11657-11662.
42. Oram JF, Lawn RM, Garvin MR, Wade DP, (2000) Abca1 is the camp-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275: 34508-34511.
43. Oram JF, (2000) Tangier disease and abca1. J. Mol. Cell Bio. Lipids 1529: 321-330.
44. Zhao Y, Chen X, Yang H, Zhou L, Okoro EU, et al. (2011) A novel function of apolipoprotein e: Upregulation of atp-binding cassette transporter a1 expression. PLoS ONE 6.
45. Chen X, Zhao Y, Guo Z, Zhou L, Okoro EU, et al, (2011) Transcriptional regulation of atp-binding cassette transporter a1 expression by a novel signaling pathway. J. Biol. Chem. 286: 8917-8923.
46. Chen X, Guo Z, Okoro EU, Zhang H, Zhou L, et al. (2012) Up-regulation of atp binding cassette transporter a1 expression by very low density lipoprotein receptor and apolipoprotein e receptor 2. J. Biol. Chem. 287: 3751-3759.
47. Havel R, Eder H, Bragdon J, (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin. Invest. 34: 1345-1353.
48. Clavey V, Lestavel-Delattre S, Bard CCJM, Fruchart JC, (1995) Modulation of lipoprotein b binding to the ldl receptor by exogenous lipids and apolipoproteins ci, cii, ciii, and e Arterioscler Thromb Vasc Biol. 15: 963-971.
49. Lee A-H, Iwakoshi NN, Glimcher1 LH (2003) Xbp-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response
50. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, et al. (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester Cancer Res. 42: 1530-1536.
51. Folch J, Lees M, Stanley GHS, (1957) A simple method for the isolation and purification of total lipides from animal tissues
52. Heeren J, Weber W, Beisiegel U, (1999) Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. J. Cell Sci. 112: 349-359.
53. Lilly-Stauderman M, Brown TL, Ambikaipakan Balasubramaniam, Harmony JAK, (1993) Heparin releases newly synthesized cellsurface-associated apolipoprotein e from hepg2 cells. J. Lipid Res. 34: 190-200.
54. Wu D, Yang H, Xiang W, Zhou L, (2005) Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoe-deficient mice J. Lipid Res. 46: 1380-1387.
55. Selva DM, Hirsch-Reinshagen V, Burgess B, Zhou S, Chan J, et al. (2004) The atp-binding cassette transporter 1 mediates lipid efflux from sertoli cells and influences male fertility. J. Lipid Res. 45: 1040-1050.
56. Huang ZH, Fitzgerald ML, Mazzone T, (2006) Distinct cellular loci for the abca1-dependent and abca1-independent lipid efflux mediated by endogenous apolipoprotein e expression Arterioscler Thromb Vasc Biol. 26: 157.
57. Chen W, Sun Y, Welch C, Gorelik A, (2001) Preferential atp-binding cassette transporter a1-mediated cholesterol efflux from late endosomes/lysosomes
58. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, (1999) Mutations in abc1 in tangier disease and familial high-density lipoprotein deficiency. Nature Genetics 22: 336-345.
59. Eck MV, Bos ST, Kaminski WE, Orsó E, Rothe G, et al. (2002) Leukocyte abca1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci 99: 6298-6303.
60. Blacklow SC, (2007) Versatility in ligand recognition by ldl receptor family proteins: Advances and frontiers. Curr Opin Struct Biol. 17: 419-426.